Given that there is a significant reduction in both NFE2L2 and NRF1 expressions in PBMCs from ALS patients, and that PGC-1α regulates both, we investigated mitochondrial biogenesis in our cellular model. The gene discussed is NFE2L2; the disease is amyotrophic lateral sclerosis.